Introduction: The prognostic outcome following progression after palliative first-line treatment for patients suffering from metastatic colorectal adenocarcinoma is generally poor. Long-term relapse-free survival with palliative second-line treatment may be achieved in only a limited number of individual cases. Case Report: A 37-year-old patient presented with bilobar liver metastases of colon cancer confirmed by histology with wild-type K-RAS (exon 2). Due to progressive disease after eight cycles of first-line therapy with FOLFIRI plus cetuximab, second-line chemotherapy with modified FOLFOX4 (mFOLFOX4) plus bevacizumab was initiated. During four cycles of mFOLFOX4 plus bevacizumab (2 months), no higher-grade toxicity occurred. Live...
BACKGROUND/AIMS: New developments in surgical techniques and strategies are modifying the indication...
BACKGROUND: In patients with colorectal liver metastases (CLM) R0 resection significantly improves o...
Colorectal cancer constitutes one of the most frequent types of cancer worldwide with 50% of patient...
Introduction: The prognostic outcome following progression after palliative first-line treatment f...
PURPOSE: Although oncosurgical strategies have demonstrated increased survival in patients with unre...
PURPOSE: Although oncosurgical strategies have demonstrated increased survival in patients with unre...
PURPOSE: Patient outcome after resection of colorectal liver metastases (CLM) following second-line ...
Colorectal cancer is the third most common cancer worldwide. Half of CRC patients develop liver meta...
Three patients, 61, 58 and 63 years old, presented with non-resectable liver metastases from colorec...
I.F. 0.499 Abstract: In recent years, wide agreement has been expressed on the value of surgical res...
Liver metastases are found in 40 % to 70 % of patients with a colorectal cancer. In nearly one third...
Approximately 25% of patients present with liver metastases at the time of the first diagnosis and u...
Introduction The gold-standard treatment for colorectal liver metastases (CLM) is liver resection. ...
Liver is the main target for colorectal cancer (CRC) metastases. About 50% of all patients affected ...
: In fit metastatic colorectal cancer (MCRC), multidisciplinary treatment strategy integrating inten...
BACKGROUND/AIMS: New developments in surgical techniques and strategies are modifying the indication...
BACKGROUND: In patients with colorectal liver metastases (CLM) R0 resection significantly improves o...
Colorectal cancer constitutes one of the most frequent types of cancer worldwide with 50% of patient...
Introduction: The prognostic outcome following progression after palliative first-line treatment f...
PURPOSE: Although oncosurgical strategies have demonstrated increased survival in patients with unre...
PURPOSE: Although oncosurgical strategies have demonstrated increased survival in patients with unre...
PURPOSE: Patient outcome after resection of colorectal liver metastases (CLM) following second-line ...
Colorectal cancer is the third most common cancer worldwide. Half of CRC patients develop liver meta...
Three patients, 61, 58 and 63 years old, presented with non-resectable liver metastases from colorec...
I.F. 0.499 Abstract: In recent years, wide agreement has been expressed on the value of surgical res...
Liver metastases are found in 40 % to 70 % of patients with a colorectal cancer. In nearly one third...
Approximately 25% of patients present with liver metastases at the time of the first diagnosis and u...
Introduction The gold-standard treatment for colorectal liver metastases (CLM) is liver resection. ...
Liver is the main target for colorectal cancer (CRC) metastases. About 50% of all patients affected ...
: In fit metastatic colorectal cancer (MCRC), multidisciplinary treatment strategy integrating inten...
BACKGROUND/AIMS: New developments in surgical techniques and strategies are modifying the indication...
BACKGROUND: In patients with colorectal liver metastases (CLM) R0 resection significantly improves o...
Colorectal cancer constitutes one of the most frequent types of cancer worldwide with 50% of patient...